Literature DB >> 10065946

Activation of excitatory amino acid receptors in bovine dental pulp evokes the release of iCGRP.

D L Jackson1, K M Hargreaves.   

Abstract

The activation of excitatory amino acid (EAA) receptors within the central nervous system is associated with numerous centrally mediated phenomena, including hyperalgesia. However, relatively little is known about the peripheral mechanisms which these receptors may regulate when activated. This research evaluated the hypothesis that EAA receptors in bovine dental pulp activate a population of peptidergic sensory neurons as measured by the release of immunoreactive calcitonin gene-related peptide (iCGRP), a neuropeptide associated with neurogenic inflammation. In vitro superfusion of bovine dental pulp was used to evaluate the regulation of iCGRP secretion by the EAA receptor agonists AMPA, kainate, NMDA, and L-glutamate. Both AMPA and kainate stimulated the release of iCGRP in a concentration-dependent manner (AMPA EC50 = 0.27 +/- 3.3 nM; kainate EC50 = 3.2 +/- 1.1 microM). Pre-treatment and co-administration of the AMPA/kainate receptor antagonist CNQX significantly reduced the iCGRP release evoked by either of these agonists. In contrast, neither NMDA nor L-glutamate induced any consistent changes in iCGRP release. These results suggest that the activation of AMPA and kainate receptors in dental pulp may contribute to peripheral release of vasoactive neuropeptides which mediate a neurogenic component of inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065946     DOI: 10.1177/00220345990780010801

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  6 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males.

Authors:  Brian E Cairns; Peter Svensson; Kelun Wang; Eduardo Castrillon; Steen Hupfeld; Barry J Sessle; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2005-11-16       Impact factor: 1.972

3.  Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.

Authors:  Peter M Zygmunt; David A Andersson; Edward D Hogestatt
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

4.  Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibers.

Authors:  Brian E Cairns; Xudong Dong; Mandeep K Mann; Peter Svensson; Barry J Sessle; Lars Arendt-Nielsen; Keith M McErlane
Journal:  Pain       Date:  2007-03-01       Impact factor: 6.961

Review 5.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

6.  Expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in the rat dental pulp and trigeminal ganglion following inflammation.

Authors:  Eun Sun Yang; Myoung Uk Jin; Jae Hyun Hong; Yun Sook Kim; So Young Choi; Tae Heon Kim; Yi Sul Cho; Yong Chul Bae
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.